Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

David Rosmarin, MA, MD

Associate Professor of Dermatology
Chair, Department of Dermatology
Indiana University School of Medicine
Indianapolis, Indiana

Disclosures

David Rosmarin, MA, MD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Abcuro; AltruBio; Arena Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Meyers Squibb Company; Celgene Corporation; Concert; CSL Behring; Dermavant; Dermira Inc.; Incyte Corporation; Janssen Pharmaceuticals; Kyowa Kirin; Lilly; Novartis Pharmaceuticals; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Revolo Biotherapeutics; Sanofi; Sun Pharmaceuticals; UCB Pharma, Inc.; VielaBio
Speaker or member of speakers bureau for: AbbVie Inc.; Amgen Inc.; Bristol Meyers Squibb Company; Celgene Corporation; Incyte Corporation; Janssen Pharmaceuticals; Lilly; Novartis Pharmaceuticals; Pfizer, Inc.; Regeneron Pharmaceuticals Inc.; Sanofi
Research funding from: AbbVie Inc.; Amgen Inc.; Bristol Meyers Squibb Company; Celgene Corporation; Dermira Inc.; Galderma Laboratories, L.P.; Incyte Corporation; Janssen Pharmaceuticals; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals; Pfizer, Inc.; Regeneron Pharmaceuticals Inc.

Raj Chovatiya, MD, PhD, MSci

Assistant Professor of Dermatology
Feinberg School of Medicine
Northwestern University
Chicago, Illinois

Disclosures

Raj Chovatiya, MD, PhD, MSci, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Apogee Therapeutics; Arcutis Biotherapeutics; Argenx; ASLAN Pharmaceuticals; Beiersdorf; Boehringer Ingelheim Pharmaceuticals, Inc. ; Bristol Myers Squibb Company; Cara Therapeutics; Dermavant; Lilly; Galderma Laboratories, L.P.; Genentech, Inc.; Incyte Corporation; LEO Pharma; L’Oréal; Novan, Inc.; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; UCB Pharma, Inc.
Speaker or member of speakers bureau for: AbbVie Inc.; Arcutis Biotherapeutics; Beiersdorf; Bristol Myers Squibb Company; Dermavant; Lilly; Incyte Corporation; LEO Pharma; Novan, Inc.; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; UCB Pharma, Inc.

Patient Advocate

Priyanka Francis

Disclosures

Priyanka Francis, has no relevant financial relationships.

Editor

Briana Betz, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Briana Betz, PhD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / CE

Putting the Patient at the Center of Care for Vitiligo

Authors: David Rosmarin, MA, MD; Raj Chovatiya, MD, PhD, MSci; Patient Advocate
CME / CE Released: 8/15/2023
Valid for credit through: 8/15/2024, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

Nurses - 0.50 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for dermatologists, pediatricians, nurse practitioners, physician assistants, and other clinicians who treat patients with vitiligo.

The goal of this activity is for learners to be better able to understand the disease burden experienced by patients and for clinicians to enhance their ability to discuss patient-centered treatment strategies.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Burden and impact of vitiligo on patients
- Evidence surrounding the mechanism, safety, and efficacy of new and emerging treatments for vitiligo
Demonstrate greater confidence in their ability to
- Provide patient-centered care that considers goal, preferences, and disease severity to patients with vitiligo

Disclosures

Faculty

David Rosmarin, MA, MD

Associate Professor of Dermatology
Chair, Department of Dermatology
Indiana University School of Medicine
Indianapolis, Indiana

Disclosures

David Rosmarin, MA, MD, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Abcuro; AltruBio; Arena Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Meyers Squibb Company; Celgene Corporation; Concert; CSL Behring; Dermavant; Dermira Inc.; Incyte Corporation; Janssen Pharmaceuticals; Kyowa Kirin; Lilly; Novartis Pharmaceuticals; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Revolo Biotherapeutics; Sanofi; Sun Pharmaceuticals; UCB Pharma, Inc.; VielaBio
Speaker or member of speakers bureau for: AbbVie Inc.; Amgen Inc.; Bristol Meyers Squibb Company; Celgene Corporation; Incyte Corporation; Janssen Pharmaceuticals; Lilly; Novartis Pharmaceuticals; Pfizer, Inc.; Regeneron Pharmaceuticals Inc.; Sanofi
Research funding from: AbbVie Inc.; Amgen Inc.; Bristol Meyers Squibb Company; Celgene Corporation; Dermira Inc.; Galderma Laboratories, L.P.; Incyte Corporation; Janssen Pharmaceuticals; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals; Pfizer, Inc.; Regeneron Pharmaceuticals Inc.

Raj Chovatiya, MD, PhD, MSci

Assistant Professor of Dermatology
Feinberg School of Medicine
Northwestern University
Chicago, Illinois

Disclosures

Raj Chovatiya, MD, PhD, MSci, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Apogee Therapeutics; Arcutis Biotherapeutics; Argenx; ASLAN Pharmaceuticals; Beiersdorf; Boehringer Ingelheim Pharmaceuticals, Inc. ; Bristol Myers Squibb Company; Cara Therapeutics; Dermavant; Lilly; Galderma Laboratories, L.P.; Genentech, Inc.; Incyte Corporation; LEO Pharma; L’Oréal; Novan, Inc.; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; UCB Pharma, Inc.
Speaker or member of speakers bureau for: AbbVie Inc.; Arcutis Biotherapeutics; Beiersdorf; Bristol Myers Squibb Company; Dermavant; Lilly; Incyte Corporation; LEO Pharma; Novan, Inc.; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; UCB Pharma, Inc.

Patient Advocate

Priyanka Francis

Disclosures

Priyanka Francis, has no relevant financial relationships.

Editor

Briana Betz, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Briana Betz, PhD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

Contact This Provider

For Nurses

Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Dermatology

CME / CE

Putting the Patient at the Center of Care for Vitiligo

Authors: David Rosmarin, MA, MD; Raj Chovatiya, MD, PhD, MSci; Patient AdvocateFaculty and Disclosures

CME / CE Released: 8/15/2023

Valid for credit through: 8/15/2024, 11:59 PM EST

processing....

Learning Feedback Questions

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

Page 1 of 4

CME / CE Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

David Rosmarin, MA, MD

Raj Chovatiya, MD, PhD, MSci

Patient Advocate

Priyanka Francis

Editor

Briana Betz, PhD

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

CME / CE

Putting the Patient at the Center of Care for Vitiligo

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

David Rosmarin, MA, MD

Raj Chovatiya, MD, PhD, MSci

Patient Advocate

Priyanka Francis

Editor

Briana Betz, PhD

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Putting the Patient at the Center of Care for Vitiligo

Learning Feedback Questions